Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Burnell

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Pharmacoepidemiology and Drug Safety|August 14, 2020
FDA postmarketing safety labeling changes: What have we learned since 2010 about impacts on prescribing rates, drug utilization, and treatment outcomesMatthew Rosenberg, Sarah Sheehan, Esther Zhou, et al.
Therapeutic Innovation & Regulatory Science|May 10, 2018
Developing and Implementing Performance Outcome Assessments: Evidentiary, Methodologic, and Operational ConsiderationsElizabeth Richardson, Jessica Burnell, Heather R Adams, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Pharmacoepidemiology and Drug Safety|August 14, 2020
FDA postmarketing safety labeling changes: What have we learned since 2010 about impacts on prescribing rates, drug utilization, and treatment outcomesMatthew Rosenberg, Sarah Sheehan, Esther Zhou, et al.
Therapeutic Innovation & Regulatory Science|May 10, 2018
Developing and Implementing Performance Outcome Assessments: Evidentiary, Methodologic, and Operational ConsiderationsElizabeth Richardson, Jessica Burnell, Heather R Adams, et al.
Pageof 1